| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/21/2009 | US20090131946 Devices and Methods for the Restoration of a Spinal Disc |
| 05/21/2009 | US20090131668 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 05/21/2009 | US20090131540 Biodegradable Magnesium Based Metallic Material for Medical Use |
| 05/21/2009 | US20090131539 Mixture |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
| 05/21/2009 | US20090131340 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 05/21/2009 | US20090131315 Treatment of Subarachnoid Hemorrhage With APO E Analogs |
| 05/21/2009 | US20090131259 Hydroxypolyamide Gel Forming Agents |
| 05/21/2009 | US20090130762 Activation of HCV-specific T cells |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130238 Composition for Preventing and Treating Hangover |
| 05/21/2009 | US20090130236 using a Sasa plant extract for treating herpes virus, influenza virus, corona virus infections |
| 05/21/2009 | US20090130232 Composition and method for treatment of oral inflammation an ulceration |
| 05/21/2009 | US20090130229 Antitumor uses of compound |
| 05/21/2009 | US20090130211 Gelled colloidal emulsion for appetite suppression |
| 05/21/2009 | US20090130198 Pharmaceutical composition with enhanced bioavailability |
| 05/21/2009 | US20090130178 Formulation for decreasing tobacco, alcohol, drug or food consumption |
| 05/21/2009 | US20090130114 Wise binding agents and epitopes |
| 05/21/2009 | US20090130102 Methods for humanizing antibodies and humanized antibodies made thereby |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130078 Treatment for Cardiovascular Disease |
| 05/21/2009 | US20090130068 Oral Tissue Regeneration and Repair |
| 05/21/2009 | US20090130064 Differentiation of stem cells and stabilization of phenotypical properties of primary cells |
| 05/21/2009 | US20090130019 Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals |
| 05/21/2009 | US20090126732 Dry powder inhalation system for transpulmonary administration |
| 05/20/2009 | EP2060585A2 Gene regulatory peptides |
| 05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 05/20/2009 | EP2060272A2 Vitamin-mitomycin conjugates |
| 05/20/2009 | EP2060271A1 Liposome and immunostimulating composition comprising the same |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2059249A2 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 05/20/2009 | EP1414451B1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | CN101437577A Combination therapy for diseases involving angiogenesis |
| 05/20/2009 | CN101437533A Antisecretory protein for use in the treatment of compartment syndrome |
| 05/20/2009 | CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists |
| 05/20/2009 | CN101434598A Preparation of cilostazol |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433611A Method for making wine for strengthening force |
| 05/20/2009 | CN100489086C Lactic acid bacteria capable of stimulating mucosal immunity |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488948C N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/20/2009 | CN100488564C Preventives/remedies for snore or respiratory disturbances during sleep |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/20/2009 | CN100488556C Chinese medicinal preparation for improving memory and its preparation method |
| 05/20/2009 | CN100488533C An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 05/20/2009 | CN100488521C Extract, production and use of cordyceps sinensis |
| 05/20/2009 | CN100488512C Compositions for treatment of cell proliferative disorders and its uses |
| 05/20/2009 | CN100488508C Pharmaceutical composition containing tetrahydroisoquinoline compounds |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488500C Use of COX-2 inhibitors for preventing immunodeficiency |
| 05/20/2009 | CN100488497C Use of leukotriene in preparing medicament |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534887 Thiazoline derivative and use of the same |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534871 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534811 Cyclic onium compounds and glucosidase inhibitors |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534799 Pyridomorphinans, thienomorphinans and use thereof |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/19/2009 | US7534772 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 05/19/2009 | US7534609 Method of expanding undifferentiated hemopoietic stem cells |
| 05/19/2009 | US7534593 Crystals of glucokinase and methods of growing them |
| 05/19/2009 | US7534456 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |
| 05/19/2009 | CA2379435C Topical azathioprine for the treatment of oral autoimmune diseases |
| 05/19/2009 | CA2323237C Improved radiation therapy methods |
| 05/19/2009 | CA2318029C Apo-2 ligand |
| 05/19/2009 | CA2317036C Novel optically active aminopentane derivatives |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/19/2009 | CA2206657C Therapeutic preparation for inhalation containing parathyroid hormone, pth |
| 05/14/2009 | WO2009062118A2 Modulation of protein trafficking |
| 05/14/2009 | WO2009061889A2 Grape polyphenolics for platelet and bacterial control |
| 05/14/2009 | WO2009061569A1 Compositions and methods for treating dysfunctional uterine bleeding |
| 05/14/2009 | WO2009061447A2 Use of umbilical cord blood in the treatment of premature birth complications |
| 05/14/2009 | WO2009060952A1 Novel preparation |
| 05/14/2009 | WO2009060865A1 Pharmaceutical composition and method for production of pharmaceutical composition |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2009060457A1 Novel synthetic analogs of sphingolipids |
| 05/14/2009 | WO2009060445A1 Synthetic sphingolipid analogs |
| 05/14/2009 | WO2009060278A1 Cyclobutyl carboxylic acid derivatives |
| 05/14/2009 | US20090124793 Corticotropin releasing factor 2 receptor agonists |
| 05/14/2009 | US20090124684 Stimulation Of CPT-1 As A Means To Reduce Weight |
| 05/14/2009 | US20090124660 Piperidine Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |